Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease. (Q38553533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Hayley L Eames

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Alastair L Corbin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

4 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

167-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26207886%20AND%20SRC:MED&resulttype=core&format=json

The IRF family transcription factors in immunity and oncogenesis

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Type I interferons keep activated T cells alive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

On the role of IRF in host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

An Atomic Model of the Interferon-β Enhanceosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Structure of IRF-1 with bound DNA reveals determinants of interferon regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Virus Infection Induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Reconstitution of virus-mediated expression of interferon alpha genes in human fibroblast cells by ectopic interferon regulatory factor-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

The Immunological Genome Project: networks of gene expression in immune cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Activation and function of interferon regulatory factor 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF5-mediated signaling and implications for SLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF5 is required for late-phase TNF secretion by human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF5 is a specific marker of inflammatory macrophages in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

The genetics and biology of Irf5-mediated signaling in lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

The RNA polymerase II core promoter: a key component in the regulation of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

On the nature of human housekeeping genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

CpG islands as gene markers in the human genome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Assessment of DNA methylation at the interferon regulatory factor 5 (IRF5) promoter region in inflammatory bowel diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

PEST sequences and regulation by proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF5:RelA interaction targets inflammatory genes in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Differential Requirement of Histone Acetylase and Deacetylase Activities for IRF5-Mediated Proinflammatory Cytokine Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Common genetic variants modulate pathogen-sensing responses in human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Nonsense-mediated mRNA decay (NMD) mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Opposed independent effects and epistasis in the complex association of IRF5 to SLE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Promoter Insertion/Deletion in the IRF5 Gene Is Highly Associated with Susceptibility to Systemic Lupus Erythematosus in Distinct Populations, But Exerts a Modest Effect on Gene Expression in Peripheral Blood Mononuclear Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Genetics research in systemic lupus erythematosus for clinicians: methodology, progress, and controversies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Possible involvement of interferon alfa in the pathogenesis of fever in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Gene expression profiling in human autoimmunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

An update of the HLA genomic region, locus information and disease associations: 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Critical role of IRF-5 in regulation of B-cell differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Development of anti-TNF therapy for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Autoantibodies in rheumatoid arthritis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Anti-CCP antibodies: the past, the present and the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Analysis ofIRF5 gene functional polymorphisms in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Evidence that cytokines play a role in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Cytokine production in culture by cells isolated from the synovial membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Murine antigen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

C57BL/6 mice need MHC class II Aq to develop collagen-induced arthritis dependent on autoreactive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Negative regulation of Toll-like-receptor signaling by IRF-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Intestinal homeostasis and its breakdown in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

NOD proteins: regulators of inflammation in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

WASP: a key immunological multitasker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Phenotypic and functional features of human Th17 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Fate mapping of IL-17-producing T cells in inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Role of Th17 Cells in the Pathogenesis of Human IBD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

A two-marker haplotype in the IRF5 gene is associated with inflammatory bowel disease in a North American cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association between genetic polymorphisms in interferon regulatory factor 5 (IRF5) gene and Malaysian patients with Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

IRF5, but not TLR4, DEFB1, or VDR, is associated with the risk of ulcerative colitis in a Han Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interleukin-23 drives intestinal inflammation through direct activity on T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac activator Dock2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Gender-dependent Expression of Murine Irf5 Gene: Implications for Sex Bias in Autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association between theIRF5rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

The CGGGG insertion/deletion polymorphism of theIRF5promoter is a strong risk factor for primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Evidence of association between interferon regulatory factor 5 gene polymorphisms and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Preferential Association of Interferon Regulatory Factor 5 Gene Variants with Seronegative Rheumatoid Arthritis in 2 Swedish Case-Control Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018

Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.018